SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060354
Filing Date
2023-11-07
Accepted
2023-11-07 16:46:25
Documents
81
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pyxs-20230930.htm   iXBRL 10-Q 2869476
2 EX-31.1 pyxs-ex31_1.htm EX-31.1 17786
3 EX-31.2 pyxs-ex31_2.htm EX-31.2 17791
4 EX-32.1 pyxs-ex32_1.htm EX-32.1 10717
5 EX-32.2 pyxs-ex32_2.htm EX-32.2 10180
6 GRAPHIC img31501454_0.jpg GRAPHIC 84132
  Complete submission text file 0000950170-23-060354.txt   9872282

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230930_lab.xml EX-101.LAB 474385
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pyxs-20230930_cal.xml EX-101.CAL 41980
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pyxs-20230930_def.xml EX-101.DEF 240373
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230930.xsd EX-101.SCH 59753
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230930_pre.xml EX-101.PRE 386447
75 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230930_htm.xml XML 1595594
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 231384750
SIC: 2834 Pharmaceutical Preparations